Kotak Healthcare Fund - Growth - Regular Plan

Other Plans and Options
  • (-0.01%)Nav, as on 30-04-2025

  • Previous Nav

  • Net Change on 30-04-2025

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The investment objective of the scheme is to seek to generate long term capital appreciation throughinvesting in equity and equity related securities of companies benefitting directly or indirectly Pharma, Healthcare, and allied sectors.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A
Nifty Healthcare Index - TRI N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
Nippon India Pharma Fund-Growth Plan-Growth Jun 05, 2004 15.44 20.01 22.50 1.82 8,080.97
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option Jul 13, 2018 20.77 24.16 25.01 1.94 4,914.64
SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH Jul 14, 1999 20.63 23.83 24.41 1.94 3,610.51
DSP Healthcare Fund - Regular Plan - Growth Nov 30, 2018 14.19 19.75 23.89 1.93 3,018.76
Mirae Asset Healthcare Fund -Regular Growth Jul 02, 2018 16.95 18.40 22.23 1.96 2,667.40

Fund Holdings as on 31-March-2025

  • SUN PHARMACEUTICAL INDUSTRIES LTD.

  • Max Healthcare Institute Ltd.

  • Cipla Ltd.

  • Divis Laboratories Ltd.

  • Torrent Pharmaceuticals Ltd.

  • JB Chemicals & Pharmaceuticals Ltd.

  • Lupin Ltd.

  • Dr.Reddy's Laboratories Ltd.

  • Aurobindo Pharma Ltd.

  • Apollo Hospitals Enterprise Ltd.

  • JUBILANT PHARMOVA LIMITED

  • Alkem Laboratories Ltd.

  • SAI LIFE SCIENCES LIMITED

  • Ami Organics Ltd

  • ASTER DM HEALTHCARE LTD

  • Ajanta Pharma Ltd.

  • Zydus Lifesciences Ltd.

  • MANKIND PHARMA LTD

  • KRISHNA INSTITUTE OF MEDICAL

  • LAXMI DENTAL LIMITED

  • Glenmark Pharmaceuticals Ltd

  • HIKAL LTD

  • Fortis Healthcare India Ltd

  • Krsnaa Diagnostics Ltd

  • Triparty Repo

  • ORCHID PHARMA LIMITED

  • YATHARTH HOSPITAL AND TRAUMA CARE SERVICES LTD

  • Marksans Pharma Ltd

  • INNOVA CAPTABS LTD

  • Net Current Assets/(Liabilities)

View More

  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Medical Equipment/Supplies/Accessories

  • Miscellaneous

View More

Fund Manager

  • Cash

  • Equity

View More

About Kotak Healthcare Fund

Scheme Analysis

Kotak Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to Kotak Mahindra Mutual Fund. It was launched on 11-Dec-2023 and currently has an AUM of ₹411.54 crore. Kotak Healthcare Fund is benchmarked against NIFTY 50 - TRI as primary index and Nifty Healthcare Index - TRI as secondary index.

The NAV of Kotak Healthcare Fund ended down ₹0(-0.01%)yesterday to ₹12.988.

Among its top 3 holdings the fund has exposure to SUN PHARMACEUTICAL INDUSTRIES LTD., and

The Kotak Healthcare Fund is managed by Abhishek Bisen and Shibani Kurian.

Fund House Contact

27 BKC, C-27, G Block, Bandra Kurla Complex, Bandra (E), Mumbai - 400 051

+91 (22) 66384400
mutual@kotak.com
+91 (22) 66384455